河北智恒医药科技股份有限公司

Country

Ownership: -

Established: 2006-02-23

Employees: -

Market Cap: -

Website: http://www.zhiheng.org

Clinical Trials

0

Active:0

Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Dapagliflozin Tablets

Product Name: 达格列净片

Approval Number: 国药准字H20253304

Approval Date: Jan 24, 2025

NMPA

Lactulose Oral Solution

Product Name: 乳果糖口服溶液

Approval Number: 国药准字H20249283

Approval Date: Nov 5, 2024

NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.